In this blog, Tech Robot will pass you through what is 3D bioprinting of tissues and organs, the benefits of 3D bioprinting, and how does 3D bioprinting work? Challenges of 3D bioprinting, future of 3D bioprinting, and more.
What is 3D bioprinting of tissues and organs?
3D bioprinting is an advanced manufacturing technology that employs bio-inks to print live cells layer by layer, creating structures that mimic the behavior and architecture of actual tissues. Bioinks used in bioprinting are natural or synthetic biomaterials which can be mixed with living cells.
How does 3D bioprinting work?
3D bioprinting technology enables researchers to study human body processes in vitro, with 3D structures having more biological significance than 2D investigations.
Its uses span tissue engineering, bioengineering, materials science, and pharmaceutical development. Modern bioprinting research involves therapeutic applications, including 3D-printed skin and bone grafts, organs, and implants.
Benefits of 3D bioprinting
1. Bioprinting may prevent cell rejection.
3D bioprinting provides a solution for organ transplants, which might be difficult owing to the high likelihood of discovering suitable tissue cells. Incompatibility can stimulate the immune system, resulting in problems and the need for a fresh transplant or immunosuppressive medication. By using cultivated cells from the patient, 3D bioprinting assures that the transplant is not rejected by the body following surgery.
2. Bioprinting could replace animals in testing labs.
As tissue manufacture advances and becomes more accessible, any cosmetics firm may have an alternative approach, such as employing printed things for product testing in which no animals are ever harmed again.
3. Bioprinting can be used to substitute volunteers in drug testing laboratories.
Bioprinted tissue may eventually replace human volunteers in drug testing facilities, decreasing volunteer health and safety hazards. In this approach, 3D bioprinting could evolve into the safest and most feasible method of testing newly created pharmaceuticals before they are released to the general public.
4. Bioprinting might replace organ donors.
Scientists are developing bioprinting technology to print living organs such as livers, kidneys, lungs, and all other organs that human bodies require. It has the potential to significantly reduce or eliminate the organ shortage, providing everyone with an equal second opportunity.
Furthermore, studies are being conducted to produce the largest and most delicate organ we have, the skin. This might also help scientists and medics patch wounds more quickly.
Challenges of 3D bioprinting
1. Bioprinters: quicker and more precise
Bioprinters, which are derived from standard inkjet printers, are employed to create cell-dense 3D structures. However, functional organ printing necessitates increases in resolution, speed, and material compatibility. New types of bioprinters, such as Cellink’s BIO X6, improve speed, detail, and usefulness.
These technologies aim to advance interaction and control in 3D microenvironments while also allowing for speedier mass manufacture of complex structures created from a variety of biomaterials and cell types.
2. Fewer alternatives in terms of biomaterials
The mechanical strength and flexibility of biomaterials make them problematic for use in functioning printed organs. Natural polymers are superior for cell adhesion, proliferation, and differentiation compared to synthetic polymers, which are robust but non-biodegradable.
To expand the variety of sources of biomaterials, scientists are looking at appropriate characteristics for biocompatible materials.
3. New approaches to preserving the form of soft materials
Maintaining structural integrity is essential for printing viable organs in three dimensions, but it can be challenging depending on the bioink development. The structure of bio-printed tissue and the seeding of cells have frequently been preserved using biodegradable scaffolds composed of biomaterials; nevertheless, the disadvantages of scaffolding include immune response induction, possible toxicity, and cell-to-cell interference from breakdown byproducts.
Highlight – The Rise of Genomic in Healthcare
3D bioprinting applications
1. 3D Bioprinting in medicine and tissue engineering
It is difficult to bioprint functioning organs because of the relationships between cell types, circulatory networks, and structural integrity. Nonetheless, it has proven possible to effectively bioprint thin or hollow tissues like cartilage and blood arteries. Stem-cell differentiated chondrocytes have been used to bioprint heart valves, cartilage, and heart tissue.
Research has demonstrated that it is possible to bioprint axisymmetric aortic valve shapes that are anatomically correct. Bioprinted tissue organoids have also been examined for liver, lung, pancreatic, brain, and skin tissues. To build vascularly linked and structurally robust structures, more study is required.
2. Using bioprinting to transplant tissues
It is difficult to bioprint functioning organs because of the relationships between cell types, circulatory networks, and structural integrity. Nonetheless, it has proven possible to effectively bioprint thin or hollow tissues like cartilage and blood arteries. Stem-cell differentiated chondrocytes have been used to bioprint heart valves, cartilage, and heart tissue.
Research has demonstrated that it is possible to bioprint axisymmetric aortic valve shapes that are anatomically correct. Bioprinted tissue organoids have also been examined for liver, lung, pancreatic, brain, and skin tissues. To link vascularization and structurally robust structures, more study is required.
3. High throughput screening and pharmaceuticals
Drug discovery requires extensive investment in testing candidate molecules. 3D bioprinted tissue models, created in high-throughput microarrays, can help in drug efficacy testing.
These tissues can be controlled for size, microarchitecture, high-throughput capability, co-culture ability, and low cross-contamination risk. For instance, a bioprinted liver micro-organ model is used for drug metabolism testing.
4. Bioprinting research for cancer
Two-dimensional tumor models are inappropriate for studying the etiology and spread of cancer because they do not capture three-dimensional interactions. Understanding these relationships in three dimensions by bioprinting enables findings that apply to therapeutic settings. Scaffold-free breast cancer models, MRC-5 fibroblasts, and human ovarian cancer cells are a few examples. These tissues remained viable in vitro for two weeks, which made it possible to examine the effects of chemotherapeutic treatments.
Future of 3D bioprinting
Advancements in bioprinting can improve patient outcomes by offering applications such as skin regeneration, cell and chemical administration, and disease modeling. With further investigation, these applications have the potential to transform the future of skin wound healing.
Conclusion
To summarize, 3D bioprinting of tissues and organs is a major leap in medical research, providing distinctive prospects for tissue and organ synthesis. This method accurately replicates the architecture of human tissues by combining bio-inks made of natural or synthetic materials with living cells. 3D bioprinting applications range from regenerative medicine and tissue engineering to pharmaceuticals and cancer research, with great potential for improved patient outcomes and drug testing. However, difficulties such as increasing bioprinter accuracy and diversifying biomaterial possibilities must be solved. As research improves, 3D bioprinting has the potential to change healthcare by lowering the need for organ donors and animal testing while improving medicinal tactics.
Leave a Reply